Evoke Pharma, Inc.

EVOK · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Assets
Cash & Equivalents$11,576$12,059$12,624$13,597
Short-Term Investments$0$0$0$0
Receivables$3,190$2,905$2,511$2,420
Inventory$600$642$532$445
Other Curr. Assets$170$325$563$776
Total Curr. Assets$15,536$15,931$16,231$17,238
Property Plant & Equip (Net)$107$123$139$154
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$0$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$6$6$6$127
Total NC Assets$113$129$145$281
Other Assets$0$0$0$0
Total Assets$15,649$16,060$16,376$17,519
Liabilities
Payables$3,916$3,588$2,781$2,041
Short-Term Debt$5,066$5,064$5,062$5,060
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$3,259$2,969$2,609$3,279
Total Curr. Liab.$12,241$11,621$10,452$10,380
LT Debt$46$65$83$101
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$0$0$0$0
Total NC Liab.$46$65$83$101
Other Liabilities$0$0$0$0
Cap. Leases$46$129$145$160
Total Liabilities$12,287$11,686$10,535$10,481
Equity
Pref Stock$0$0$0$0
Common Stock$0$0$0$0
Retained Earnings-$132,825-$131,669-$130,098-$128,792
AOCI$0$0$0-$0
Other Equity$136,187$136,043$135,939$135,829
Total Equity$3,362$4,374$5,841$7,038
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$15,649$16,060$16,376$17,519
Net Debt-$6,464-$6,930-$7,479-$8,436